Axxam SpA is a member of the RESOLUTE consortium

Milan, 4th July 2018.

Axxam is proud to announce its participation to the RESOLUTE (Research empowerment on solute carriers) consortium, a public-private research partnership supported by the Innovative Medicines Initiative (IMI), to accelerate research in the field of solute carrier (SLC) class of transporters and to potentially establish them as a novel target classes for effective new therapies. Axxam will make available its expertise in cell-based assays and high-throughput screening in order to contribute to the success of the project.

For more information please open the Press Release from the RESOLUTE consortium.

Open PDF document